Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.
Average price paid is weighted by shares, so a large purchase counts for more than a small one. It is what insiders reported paying, not a target or a fair value.
Insider flow: Buying only — a count of disclosed transactions, not a rating or a recommendation.
Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.
Share-weighted average price across 4 reported purchases, with the full range of prices paid. Purchases only — averaging a sale into an "insider cost" would describe a price nobody paid.
One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.
Every open-market transaction disclosed for BIVI in the synced window. Values are the insider's own, as filed.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-08-28 | Palumbo Joseph M | Chief Medical Officer | Open-market buy | 4,843 | 2.16 | $10,461 |
| 2026-08-28 | Chappell Amy Suzon | Director | Open-market buy | 727 | 2.16 | $1,570 |
| 2026-08-28 | KIM JOANNE WENDY | Chief Financial Officer | Open-market buy | 2,500 | 2.18 | $5,450 |
| 2026-08-27 | DO CUONG V | President & CEO | Open-market buy | 15,210 | 2.08 | $31,637 |
Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.